2007 Trends and Determinants of Severe Morbidity in HIV-infected Patients... HIV in the UK 1980?2006: Reconstruction Using a Model of HIV Infection... Three-dimensional Laser Scanning for the Assessment of Facial Fat Changes... Hyaluronic Acid Treatment of Facial Fat Atrophy in HIV-positive Patients... Long-term Benefits of Genotypic Resistance Testing in Patients... Placebo-controlled Trial of Metformin... A Standardized, Comprehensive Magnetic Resonance Imaging Protocol... Immunological and Virological Responses to Initial Antiretroviral Therapy... Impact of Widespread Availability of Postexposure Prophylaxis Against HIV... Interactions Between Protease Inhibitors and Acid-reducing Agents... Management of Dyslipidaemias in Antiretroviral-treated HIV Infection... Treatment of Chronic Hepatitis C in HIV-infected Patients: A Meta-analysis... CAM Use Among Multistate, Multisite Cohort of People Living With HIV/AIDS... Serum Lipids Changes in HIV Males on Highly Active Antiretroviral Therapy... Performance of a WHO First-line Regimen in Antiretroviral-naive Individuals... Clinical Benefits of Ritonavir-boosted TMC114 From Effects on CD4 and RNA... Inhibitory Quotient as a Prognostic Factor of Response to a Salvage ART... Incidence and Causes of Death in HIV-infected Persons Receiving HAART... Gastric Acid-reducing Agents Is Frequent Among HIV-1-infected Patients... Combination ART Without a Nucleoside Reverse Transcriptase Inhibitor... Long-term Evolution of CD4 Count in Patients With Plasma HIV RNA <500... Susceptibility to Opportunistic Infections in HIV-infected Patients... CD4 Cell Count and Initiation of Antiretroviral Therapy: Trends in the UK... Long-term Survival of HIV-infected Patients Treated with Highly Active ART... Interaction Between Rifampicin and Ritonavir-boosted Atazanavir... Superior Virological Response to Boosted Protease Inhibitor-based ART... Interruption of Combination ART and Risk of Clinical Disease Progression... Safety of Nevirapine in Pregnancy... Treatment Outcomes Amongst Antiretroviral-naive HIV-infected Patients... Community-based Rapid HIV Testing in Homeless and Marginally Housed Adults... Reviews in Antiretroviral Therapy: Once-daily Nevirapine Dosing... 2006 BHIVA Guidelines for the Treatment of HIV-infected Adults with ART... Antiretroviral Treatment and Age-related Comorbidities in Older HIV Patient... Efavirenz and Chronic Neuropsychiatric Symptoms... Lipid Abnormalities in HIV/hepatitis C Virus-coinfected Patients... Evaluation of Hypophosphataemia in TDF-exposed and TDF-unexposed... Serum Prostate-specific Antigen Levels in Older Men with or at Risk of HIV ... Low-level Viraemia and Virological Failure in HIV-1-infected Patients... Resistance Development over 144 Weeks in Treatment-naive Patients... CD4 Percentage is an Independent Predictor of Survival in Patients... Community-Onset Methicillin-Resistant Staphylococcus aureus ... Pulmonary Kaposi Sarcoma & Highly Active Antiretroviral Therapy... Adherence to Therapy and Virological Suppression With HAART... Myocardial Infarctions in HIV-Infected Patients... HIV-Infected Travellers to the USA... Nandrolone Decanoate Compared with Placebo or Testosterone... Guidelines for Kidney Transplantation in Patients with HIV ... Ritonavir-Boosted Saquinavir... Effects of HAART on Paediatric Metabolite Levels... Impact of HAART on Blood Pressure in HIV-Infected Patients... 2005 Calculated Creatinine Clearance and Anion-Gap... Impact of Antiretroviral Choice on Hypercholesterolaemia Events... The Effect of Low-Dose Ritonavir Monotherapy... ART Associated With Increased Apolipoprotein CIII in HIV + Males... The Role of Diet, Exercise and Smoking in Dyslipidemia in... The Use of a Triple Nucleoside-Nucleotide Regimen for... Osteoprotegerin and Bone Turnover Markers in Heavily Pretreated ... Impact of Highly Active Antiretroviral Therapy on Organ-Specific... Effects of HIV Disease on Lipid, Glucose and Insulin Levels:... Extended Antiretroviral Treatment Interruption in HIV-Infected... Emergence of Invasive Cerebral Aspergillosis in an HIV-Positive ... 2004 An Algorithm-Based Genotypic Resistance Score is Associated With... Effect of Concurrent Zidovudine Use on the Resistance Pathway... Is the Salk Principle Still Viable for the Design of an... Resistance Profiles and Adherence at Primary Virological Failure... A Prospective Multicentre Study of Discontinuing Prophylaxis for... Clinical Implications of Stopping Nevirapine-Based... A Multicentre, Randomized, Double-Blind, Placebo-Controlled... The High Cost of Medical Care for Patients Who Present Late... Pharmacokinetics of Emtricitabine, Didanosine and Efavirenz... Nevirapine-Versus Efavirenz-Based HAART... Differential CD4 T-Cell Response in HIV-1-Infected Patients... Highly Active Antiretroviral Therapy Impact on Immune Recovery... Long-Term Highly Active Antiretroviral Treatment Efficacy... Depletion of Mitochondrial DNA in Dual vs. Single NRTI Treatment... Protease Inhibitors in Nucleoside-Experienced Patients... 2003 Epidemiological Risk Factors for Reactions to Abacavir... Reduced Zidovudine Susceptibility in Zidovudine-Naive HIV-1... Matched Case-Control Study Evaluating Hyperlactataemia Risk... Factors Associated With a Reduced CD4 Lymphocyte Count Response... Low-Dose Indinavir in Combination With Low-Dose Ritonavir... Fat Distribution Is Altered in HIV-Infected Men... HIV/HBV and HIV/HCV Coinfection... | 
